Kelderman Kim (CIK 1739054) reported 18 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-10). Recent activity: Buy CNMD (500 shares), Buy TECH (21,470 shares), Sell TECH (10,821 shares), Buy TECH (35,000 shares), Sell TECH (28,686 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | CONMED Corp (CNMD) | Director | Buy | 500 | $0 |
| 2026-08-18 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 21,470 | $0 |
| 2026-08-18 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 10,821 | $783,440 |
| 2026-07-30 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 35,000 | $1.7M |
| 2026-07-30 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 28,686 | $2.1M |
| 2026-05-07 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 26,692 | $1.3M |
| 2026-05-07 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 23,951 | $1.4M |
| 2026-04-24 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 11,344 | $0 |
| 2026-04-24 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 1,363 | $79,845 |
| 2026-04-16 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 36,500 | $0 |
| 2026-04-16 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 32,088 | $1.9M |
| 2025-11-05 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 2,303 | $144,099 |
| 2025-08-19 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 8,543 | $0 |
| 2025-08-19 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 4,305 | $230,748 |
| 2025-07-24 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 48,176 | $2.1M |
| 2025-07-24 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 43,649 | $2.3M |
| 2025-07-17 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Buy | 36,132 | $1.6M |
| 2025-07-17 | BIO-TECHNE Corp (TECH) | Chief Executive Officer | Sell | 32,933 | $1.7M |
来源：SEC Form 4 申报文件 · 截至 2026-09-10